CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I, Randomized, Open-label, Parallel-group Study to Determine the Pharmacokinetics, Safety, and Tolerability of MSB11022 (Proposed Adalimumab Biosimilar) Following a Single Subcutaneous Injection by an Auto-injector or by a Pre-filled Syringe in Healthy Subjects

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04018599
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:46.600210+00:00
Published At: 2020-03-25T00:00:00+00:00
Record Updated At: 2020-03-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rheumatoid Arthritis", "Polyarticular Juvenile Idiopathic Arthritis", "Psoriatic Arthritis", "Ankylosing Spondylitis", "Crohn Disease", "Ulcerative Colitis", "Plaque Psoriasis", "Pediatric Plaque Psoriasis", "Pediatric Crohns Disease", "Hidradenitis Suppurativa", "Non-infectious Uveitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-03-25"
protocolSection.identificationModule.nctId: "NCT04018599"
protocolSection.identificationModule.officialTitle: "A Phase I, Randomized, Open-label, Parallel-group Study to Determine the Pharmacokinetics, Safety, and Tolerability of MSB11022 (Proposed Adalimumab Biosimilar) Following a Single Subcutaneous Injection by an Auto-injector or by a Pre-filled Syringe in Healthy Subjects"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.